About Us
ViewsML is transforming spatial biology for translational research and precision medicine using AI deep learning. By virtualizing immunohistochemistry (IHC) and biomarkers - and thus bypassing this wet lab process - we give researchers back 100% of their IHC time, 50% of their budget and richer data sets.
Meet Our Team
Kenneth To, PhD, MBA
Chief Executive Officer
Serial entrepreneur, expertise in medical affairs, marketing, and product management. ElI Lilly & Co., Stemcell Technologies, Wax-it Histology Services ( co-founder).
Keith Jalbert, BBA
Chief Commercial Officer
Sales strategy, execution, previously responsible for growing $300M business to $1.6B across 120 sales representatives. Synnex, Baxter, Novartis.
Christopher Jackson, MD, MEng
Chief Scientific Officer
Co-inventor of virtual IHC technology, clinical pathologist, and AI computer scientist. Massachusetts General Hospital, Dartmouth Hitchcock Medical Center.
George Hennen, MBA, CISM
Chief Technology Officer
R&D strategy, product development, cybersecurity, AI. Cisco, GE Healthcare, NASA.
Rafay Azhar, MBBS, FRCPath(UK)
Medical Director
20+ years anatomical pathologist, digital pathology. University of Ottawa, Singapore General Hospital, Freeman Hospital Newcastle.